drugs
|
specialties
|
education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Thailand
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Others Services
Download App
Thailand
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
drugs
|
specialties
|
education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
MIMS home
Drugs
Info
Levomet
Levomet
carbidopa + levodopa
Manufacturer:
Unison
Distributor:
Medline
Concise Prescribing Info
Contents
Per 100/25 tab
Levodopa 100 mg, carbidopa 25 mg.
Per 250/25 tab
Levodopa 250 mg, carbidopa 25 mg
Indications/Uses
Parkinsonism.
Dosage/Direction for Use
125-275 mg tid titrated to individual needs.
Administration
Should be taken on an empty stomach: May be taken w/ meals if GI discomfort occurs.
Special Precautions
Not recommended for the treatment of drug-induced extrapyramidal reactions.
Adverse Reactions
Dyskinesia, dystonia & other involuntary movements. Hallucination.
View
ADR Monitoring Form
Drug Interactions
Discontinue TCA, antihypertensives 2 wk prior to therapy.
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor ; Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
Thai FDA Category
D
Presentation/Packing
Form
Levomet 100/25 tab
Packing/Price
10 × 10's
Form
Levomet 250/25 tab
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in